Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Duration of checkpoint inhibitor therapy

Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany
Duration of checkpoint inhibitor therapy ( Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany )
17 May 2017

PD1/ CTLA4 : Upfront or sequentially?

Prof Christoph Höller - Medical University of Vienna, Vienna, Austria
PD1/ CTLA4 : Upfront or sequentially? ( Prof Christoph Höller - Medical University of Vienna, Vienna, Austria )
17 May 2017

Deregulated TGF-β superfamily signalling in cancer

Dr Caroline Hill - Francis Crick Institute, London, UK
Deregulated TGF-β superfamily signalling in cancer ( Dr Caroline Hill - Francis Crick Institute, London, UK )
17 May 2017

The potential of aspirin in the prevention and treatment of cancer

Dr Gareth Morgan - Cardiff University, Cardiff, UK
The potential of aspirin in the prevention and treatment of cancer ( Dr Gareth Morgan - Cardiff University, Cardiff, UK )
17 May 2017

Functions of BRCA1 and the implications for treatment

Dr Jo Morris - University of Birmingham, Birmingham, UK
Functions of BRCA1 and the implications for treatment ( Dr Jo Morris - University of Birmingham, Birmingham, UK )
15 May 2017

Genetic determinants of breast cancer immune phenotypes

Dr Giuseppe Curigliano - European Institute of Oncology, Milan, Italy
Genetic determinants of breast cancer immune phenotypes ( Dr Giuseppe Curigliano - European Institute of Oncology, Milan, Italy )
12 May 2017

IMPAKT conference highlights

Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal
IMPAKT conference highlights ( Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal )
12 May 2017

Mutational landscapes in pregnant and non-pregnant breast cancer

Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany
Mutational landscapes in pregnant and non-pregnant breast cancer ( Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany )
12 May 2017

Resistance to CDK4/6 inhibitors

Dr Nicholas Turner - The Institute of Cancer Research, London, UK
Resistance to CDK4/6 inhibitors ( Dr Nicholas Turner - The Institute of Cancer Research, London, UK )
12 May 2017

Deciphering the connection of genetics, immune infiltration and prognosis

Dr Jan Budczies - Charité Universitätsmedizin Berlin, Berlin, Germany
Deciphering the connection of genetics, immune infiltration and prognosis ( Dr Jan Budczies - Charité Universitätsmedizin Berlin, Berlin, Germany )
12 May 2017

Genetic vs immune strategies in breast cancer

Prof Fabrice André - Institut Gustave Roussy, Paris, France
Genetic vs immune strategies in breast cancer ( Prof Fabrice André - Institut Gustave Roussy, Paris, France )
12 May 2017

Transforming patient care through translational research

Prof Aleix Prat - Hospital Clinic of Barcelona, Barcelona, Spain
Transforming patient care through translational research ( Prof Aleix Prat - Hospital Clinic of Barcelona, Barcelona, Spain )
12 May 2017